Table 1.
Basic Characteristics of Patients with or without NAFLD (n = 128). Data were expressed as mean±standard deviation (SD), median (inter-quartile range) or number (percent). T2DM: type 2 diabetes mellitus; ALT: alanine aminotransferase; AST: aspartate transaminase; r-GT: r-glutamyl transpeptidase; HDL: high-density lipoprotein; LDL: low-density lipoprotein; BMI: body mass index; TC: total cholesterol; TG: triglyceride; SBP: systemic blood pressure; NLR: neutrophil lymphocyte ratio; NIHSS: The National Institutes of Health Stroke Scale.
|
Variables |
NAFLD with ICH (n = 34) |
ICH (n = 94) |
p value |
|---|---|---|---|
| Male | 26 (76.47%) | 64 (68.08%) | 0.359 |
| Age (years) | 62.4 ± 13.6 | 63.6 ± 11.7 | 0.617 |
| Hypertension, n (%) | 30 (88.23%) | 69 (73.40%) | 0.077 |
| T2DM, n (%) | 12 (35.29%) | 12 (12.76%) | 0.004 |
| Heart disease, n (%) | 5 (14.71%) | 7 (7.45%) | 0.300 |
| ALT (U/L) | 20 (14.8–25) | 14 (9–21) | 0.003 |
| AST (U/L) | 23 (16.8–30.3) | 18 (16–24) | 0.056 |
| r-GT(U/L) | 25.5 (21.8–42.5) | 24 (16–36) | 0.172 |
| HDL (mmol/l) | 1.0 (0.8–1.2) | 1.08 (0.9–1.3) | 0.069 |
| LDL (mmol/l) | 2.4 (1.8–2.8) | 2.2 (1.7–2.8) | 0.569 |
| BMI (kg/m2) | 25.33 ± 2.39 | 23.11 ± 2.74 | <0.0001 |
| TG (mmol/l) | 1.4 (1.0–2.8) | 1.2 (0.8–1.5) | 0.004 |
| TC (mmol/l) | 4.2 (3.4–4.9) | 4.1 (3.4–4.9) | 0.747 |
| SBP(mmHg) | 106.8 (93.3–117.5) | 104.5 (95–114) | 0.233 |
| NLR | 2.6 (1.9–5.8) | 3.4 (1.9–5.8) | 0.314 |
| Infection, n (%) | 7 (20.6%) | 13 (13.8%) | 0.410 |
| Unfavorable outcome, n (%) | 4 (12.8%) | 12 (11.8%) | 1 |
| Hemorrhage location | |||
| Deep, n( %) | 19 (55.9%) | 43 (45.7%) | 0.311 |
| Labor, n (%) | 12 (35.3%) | 38 (40.4%) | 0.599 |
| Brainstem, n (%) | 0 | 11 (11.7%) | 0.036 |
| Cerebellum, n (%) | 3 (8.8%) | 2 (2.1%) | 0.116 |
| NIHSS at admission | 5 (4–8.3) | 5 (2–11) | 0.646 |
| NIHSS at discharge | 3 (1–5) | 3 (1–6.3) | 0.929 |
| Treatment | 0.180 | ||
| Surgical | 1 (4%) | 11 (11.7%) | |
| Medical | 33 (94%) | 83 (88.3%) |